Feng Zhang (張鋒), a 2016 Tang Prize winner, explained his latest genome editing tool, called CRISPR/Cas13, in a meeting Wednesday with Tang Prize Foundation CEO Chern Jenn-chuan (陳振川) and a Nobel Prize laureate in Physiology or Medicine at the Massachusetts Institute of Technology (MIT).
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
5 injured in collision between Taichung bus and car
12/21/2024 08:21 PM - Science & Tech
Taiwan plans to set up drone testing facility in Chiayi
12/21/2024 06:25 PM - Cross-Strait
Experts sound alarm over low awareness of China threat among Taiwan's youth
12/21/2024 06:08 PM - Society
5 released on bail over deadly fire at Taichung PX Mart facility
12/21/2024 05:45 PM - Politics
Taiwan's Cabinet to take countermeasures after contentious amendments passed
12/21/2024 04:18 PM